drugset / Trial / NCT06055816
Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
Timeline
- Start
- 2023-10-24
- Primary completion
- 2026-05-09
- Completion
- 2028-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Endostar | Protein / enzyme biologic | 150 mg | — |
| Subject | Envafolimab | Monoclonal antibody | 240 mg | — |
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | — |